Search Results - "Rooney, Michael D."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Dysregulated skin barrier function in Tmem79 mutant mice promotes IL‐17A‐dependent spontaneous skin and lung inflammation by Saunders, Sean P., Floudas, Achilleas, Moran, Tara, Byrne, Ciara M., Rooney, Michael D., Fahy, Caoimhe M. R., Geoghegan, Joan A., Iwakura, Yoichiro, Fallon, Padraic G., Schwartz, Christian

    Published in Allergy (Copenhagen) (01-12-2020)
    “…Background Atopic dermatitis (AD) is associated with a dysregulation of the skin barrier and may predispose to the development of secondary allergic…”
    Get full text
    Journal Article
  2. 2

    Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis by Rooney, Michael K, Santiago, Gaia, Perni, Subha, Horowitz, David P, McCall, Anne R, Einstein, Andrew J, Jagsi, Reshma, Golden, Daniel W

    Published in Journal of patient experience (2021)
    “…Comprehensive patient education is necessary for shared decision-making. While patient–provider conversations primarily drive patient education, patients also…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Trends in Publication Speed of Radiation Oncology Research from 2010 to 2019 by Rooney, Michael K., Nesbit, Eric G., Holliday, Emma B., Jagsi, Reshma, Fuller, Clifton D., Ludmir, Ethan B., Sachdev, Sean

    Published in Advances in radiation oncology (01-03-2022)
    “…In this investigation, we aimed to describe trends in time to acceptance (TTA) and time to online publication (TTOP) of research published in leading radiation…”
    Get full text
    Journal Article
  5. 5

    Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis by Corrigan, Kelsey L., De, Brian, Rooney, Michael K., Ludmir, Ethan B., Das, Prajnan, Smith, Grace L., Taniguchi, Cullen M., Minsky, Bruce D., Koay, Eugene J., Koong, Albert C., Holliday, Emma B.

    Published in Advances in radiation oncology (01-07-2022)
    “…Pelvic chemoradiation therapy (CRT) is the curative therapy for non-metastatic anal cancer, resulting in excellent survival rates. However, anal cancer…”
    Get full text
    Journal Article